Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Scutellariae radix, known as Huang Qin (黄芩) in Chinese, is the dried root of Scutellaria baicalensis Georgi. It is a traditional Chinese medicinal herb with a long history of use for clearing heat, drying dampness, purging fire, removing toxins, and preventing miscarriage. The main bioactive constituents are flavonoids—primarily baicalein, wogonin, oroxylin A (aglycones), and their glycosides (baicalin, wogonoside, oroxylin A-7-glucuronide). These compounds exhibit anti-inflammatory, antipyretic (fever-reducing), anticancer and antiviral activities. In Traditional Chinese Medicine (TCM), it is used to treat conditions such as fever, dysentery, jaundice, coughs due to lung heat or infection; it also has applications in hypertension and skin infections. Modern research supports its potential for treating inflammation-related diseases and certain cancers[1][2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on scutellariae radix.